Deutsche Cannabis Liabilities 2024

Deutsche Cannabis Liabilities

0 EUR

Deutsche Cannabis Dividend yield

Ticker

HEMP.F

ISIN

DE000A0BVVK7

WKN

A0BVVK

In 2024, Deutsche Cannabis's total liabilities amounted to 0 EUR, a 0% difference from the 0 EUR total liabilities in the previous year.

Deutsche Cannabis Aktienanalyse

What does Deutsche Cannabis do?

The German Cannabis AG is a rising company that specializes in the production and sale of medical cannabis. The company was founded in 2018 and is headquartered in Frankfurt am Main. The history of the German Cannabis AG began when a group of investors came together to invest in the growing market for medical cannabis. They recognized the potential that cannabis has as a medical product and the growing demand for high-quality cannabis. The founders of the company made it their mission to breed the best hemp varieties and extract the active ingredients in order to deliver the highest possible quality to their customers. The business model of the German Cannabis AG is based on growing and distributing medical cannabis. The company has its own plantation in Portugal, where it grows cannabis in modern greenhouses. The cultivation area is currently around 30 hectares and is planned to be expanded in the future. The company is committed to meeting the highest quality standards and therefore relies on state-of-the-art technologies and processes. For example, only organic-certified seeds are used to ensure optimal quality and purity of the end product. The German Cannabis AG offers various divisions to meet the different needs of customers. These divisions include not only medical cannabis but also CBD products, cosmetics, and dietary supplements. In the medical cannabis division, the company seeks to provide doctors and patients with high-quality and reliable products. The individual needs and specific requirements are the main focus. The company produces various products such as oils, capsules, flowers, or extracts that are tailored to the needs of patients. These products are sold exclusively to pharmacies and are available by prescription only. The CBD products division includes oils, cosmetics, and dietary supplements based on cannabidiol (CBD). These products are legal and can be purchased online or in specialty stores without a prescription. The company also places great emphasis on quality and reliability in this division and conducts intensive research and development. The cosmetics division includes various products such as creams, ointments, and balms based on medical cannabis. These are specifically offered for the treatment of skin problems such as eczema, psoriasis, or skin inflammation. Natural ingredients are used, and synthetic products are avoided. The dietary supplements division is characterized by high-quality products such as capsules, powders, or oils enriched with medical cannabis. These products support the immune system, digestion, and overall vitality of the body. In summary, the German Cannabis AG is a rising company specializing in the production and sale of medical cannabis and related products. Quality and reliability are the focus, and intensive investment is made in research and development. The different divisions offer customers a wide range of products that are individually tailored to their needs. Deutsche Cannabis ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Deutsche Cannabis's Liabilities

Deutsche Cannabis's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Deutsche Cannabis's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Deutsche Cannabis's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Deutsche Cannabis's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Deutsche Cannabis’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Deutsche Cannabis Stock

What is the level of liabilities of Deutsche Cannabis this year?

Deutsche Cannabis has a debt balance of 0 EUR this year.

What were the liabilities of Deutsche Cannabis compared to the previous year?

The liabilities of Deutsche Cannabis have increased by 0% dropped compared to the previous year.

What are the consequences of high debt for investors of Deutsche Cannabis?

High liabilities can pose a risk for investors of Deutsche Cannabis, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Deutsche Cannabis?

Low liabilities mean that Deutsche Cannabis has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Deutsche Cannabis affect the company?

An increase in liabilities of Deutsche Cannabis can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Deutsche Cannabis affect the company?

A decrease in the liabilities of Deutsche Cannabis can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Deutsche Cannabis?

Some factors that can influence the liabilities of Deutsche Cannabis include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Deutsche Cannabis so important for investors?

The liabilities of Deutsche Cannabis are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Deutsche Cannabis take to modify the liabilities?

To change its liabilities, Deutsche Cannabis can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Deutsche Cannabis pay?

Over the past 12 months, Deutsche Cannabis paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Deutsche Cannabis is expected to pay a dividend of 0 EUR.

What is the dividend yield of Deutsche Cannabis?

The current dividend yield of Deutsche Cannabis is .

When does Deutsche Cannabis pay dividends?

Deutsche Cannabis pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Deutsche Cannabis?

Deutsche Cannabis paid dividends every year for the past 0 years.

What is the dividend of Deutsche Cannabis?

For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.

In which sector is Deutsche Cannabis located?

Deutsche Cannabis is assigned to the 'Communication' sector.

Wann musste ich die Aktien von Deutsche Cannabis kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Deutsche Cannabis from 5/23/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 5/23/2024.

When did Deutsche Cannabis pay the last dividend?

The last dividend was paid out on 5/23/2024.

What was the dividend of Deutsche Cannabis in the year 2023?

In the year 2023, Deutsche Cannabis distributed 0 EUR as dividends.

In which currency does Deutsche Cannabis pay out the dividend?

The dividends of Deutsche Cannabis are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Deutsche Cannabis stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Deutsche Cannabis

Our stock analysis for Deutsche Cannabis Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Deutsche Cannabis Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.